Wednesday, July 24, 2024
HomeArtificial IntelligenceMusk’s Neuralink to start human trial of brain implant for paralysis patients

Musk’s Neuralink to start human trial of brain implant for paralysis patients

Billionaire entrepreneur Elon Musk’s brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to begin recruitment for the first human trial of its brain implant for paralysis patients.

Those with paralysis due to cervical spinal cord injury or amyotrophic lateral sclerosis may qualify for the study, it said, but did not reveal how many participants would be enrolled in the trial, which will take about six years to complete.

The study will use a robot to surgically place a brain-computer interface (BCI) implant in a region of the brain that controls the intention to move, Neuralink said, adding that its initial goal is to enable people to control a computer cursor or keyboard using their thoughts alone.

The company, which had earlier hoped to receive approval to implant its device in 10 patients, was negotiating a lower number of patients with the U.S. Food and Drug Administration (FDA) after the agency raised safety concerns, according to current and former employees. It is not known how many patients the FDA ultimately approved.

Most Read 1Chandrayaan-3 mission: Dawn breaks on Moon, all eyes on lander, rover to wake up 2As Indo-Canadian relations sour, anxiety grips Indian students, residents who wish to settle in Canada 3Karan Johar says Sanjay Leela Bhansali did not call him after Rocky Aur Rani: ‘He’s never called me but…’ 4Gadar 2 box office collection day 40: Hit by Shah Rukh Khan’s Jawan onslaught, Sunny Deol movie ends BO run with Rs 45 lakh earning 5Shubh’s tour in India cancelled: Why is the Canada-based singer facing the music?

Musk has grand ambitions for Neuralink, saying it would facilitate speedy surgical insertions of its chip devices to treat conditions like obesity, autism, depression and schizophrenia.

In May, the company said it had received clearance from the FDA for its first-in-human clinical trial, when it was already under federal scrutiny for its handling of animal testing.

Also ReadWhy it’s time for Amazon’s Alexa to get a makeoverGoogle Bard integrates Gmail, Docs, Drive & more: Check out these cool ne…Amazon makes Alexa ‘smarter’ as the generative AI arms race gets fierceNeed a professional LinkedIn profile picture? This AI tool will help

Even if the BCI device proves to be safe for human use, it would still potentially take more than a decade for the startup to secure commercial use clearance for it, according to experts.

© IE Online Media Services Pvt Ltd

RELATED ARTICLES
- Advertisment -

Most Popular